Literature DB >> 28410660

Late-Onset Alzheimer Disease.

Aimee L Pierce1, Szofia S Bullain2, Claudia H Kawas3.   

Abstract

The oldest-old represent the fastest growing segment of society, and the risk of developing dementia continues to increase with advancing age into the 9th and 10th decades of life. The most common form of dementia in the oldest-old is Alzheimer disease (AD), although there are often mixed pathologies contributing to dementia in addition to amyloid plaques and neurofibrillary tangles. Diagnosing AD in the oldest-old is challenging due to cognitive and physical changes associated with aging. Treatment remains supportive, with current approved medications able to provide modest symptomatic benefit but unable to slow the progression of disease.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Dementia; Late-onset; Oldest-old; Pathology

Mesh:

Year:  2017        PMID: 28410660     DOI: 10.1016/j.ncl.2017.01.006

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  9 in total

Review 1.  Involvement of Astrocytes in Alzheimer's Disease from a Neuroinflammatory and Oxidative Stress Perspective.

Authors:  Rodrigo E González-Reyes; Mauricio O Nava-Mesa; Karina Vargas-Sánchez; Daniel Ariza-Salamanca; Laura Mora-Muñoz
Journal:  Front Mol Neurosci       Date:  2017-12-19       Impact factor: 5.639

Review 2.  Of Energy and Entropy: The Ineluctable Impact of Aging in Old Age Dementia.

Authors:  Virginia Boccardi; Chiara Comanducci; Marta Baroni; Patrizia Mecocci
Journal:  Int J Mol Sci       Date:  2017-12-09       Impact factor: 5.923

Review 3.  Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview.

Authors:  María Alejandra Cerquera-Jaramillo; Mauricio O Nava-Mesa; Rodrigo E González-Reyes; Carlos Tellez-Conti; Alejandra de-la-Torre
Journal:  Neural Plast       Date:  2018-10-14       Impact factor: 3.599

Review 4.  Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes.

Authors:  Valerio Caputo; Andrea Termine; Claudia Strafella; Emiliano Giardina; Raffaella Cascella
Journal:  World J Diabetes       Date:  2020-05-15

5.  Reduction of Aβ Generation by Schisandrin B through Restraining Beta-Secretase 1 Transcription and Translation.

Authors:  Zeng Li; Xiao-Chang Liu; Rui Li; Jun Chang
Journal:  Med Sci Monit       Date:  2018-02-28

Review 6.  Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications.

Authors:  Andrea Tumminia; Federica Vinciguerra; Miriam Parisi; Lucia Frittitta
Journal:  Int J Mol Sci       Date:  2018-10-24       Impact factor: 5.923

Review 7.  The Genetics of Alzheimer's Disease in the Chinese Population.

Authors:  Chen-Ling Gan; Tao Zhang; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

Review 8.  Complex Interaction between Resident Microbiota and Misfolded Proteins: Role in Neuroinflammation and Neurodegeneration.

Authors:  Juliana González-Sanmiguel; Christina M A P Schuh; Carola Muñoz-Montesino; Pamina Contreras-Kallens; Luis G Aguayo; Sebastian Aguayo
Journal:  Cells       Date:  2020-11-13       Impact factor: 6.600

Review 9.  Amyloid Beta Dynamics in Biological Fluids-Therapeutic Impact.

Authors:  Thomas Gabriel Schreiner; Bogdan Ovidiu Popescu
Journal:  J Clin Med       Date:  2021-12-20       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.